跳至主要内容
临床试验/NL-OMON29520
NL-OMON29520已完成不适用

Dose response study in growth hormone therapy of growth hormone deficient children follow-up (> 2years) study.

ovo Nordisk A/S Denmark0 个研究点目标入组 35 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
35

研究概览

简要总结

de Muinck Keizer-Schrama SM, Rikken B, Wynne HJ, Hokken-Koelega AC, Wit JM, Bot A, Drop SL 1992 Dose-response study of biosynthetic human growth hormone (GH) in GH-deficient children: effects on auxological and biochemical parameters. Dutch Growth Hormone Working Group. J Clin Endocrinol Metab74:898-905

- De Muinck Keizer-Schrama S, Rikken B, Hokken-Koelega A, Wit JM, Drop S 1994 Comparative effect of two doses of growth hormone for growth hormone deficiency. The Dutch Growth Hormone Working Group. Arch Dis Child 71:12-18

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Documented GHD of organic or idiopathic origin, including isolated GHD as well as multiple pituitary hormone deficiencies;
  • 2. BA < 12 for boys and < 10 yr for girls, determined according to the procedure of Tanner and Whitehouse, 20 bones (TW2-20)

排除标准

  • 1. Growth retardation due to diabetes mellitus, inborn error of metabolism, primary bone disease, disorders of cardiopulmonary, gastrointestinal, genitourinary, or nervous tracts, or serious suspicion of psychosocial dwarfism;
  • 2. Any kind of drug that might interfere with GH therapy, with the exception of replacement doses of T4 and/or hydrocortisone in multiple hormone deficiencies;

研究者

发起方
ovo Nordisk A/S Denmark

相似试验